Plain-English translation of NCT03116412 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After surgery for advanced melanoma, doctors want to know the best way to monitor you for cancer recurrence. This trial compares two approaches: routine doctor visits alone, or routine visits plus additional imaging scans (CT or PET scans) and blood tests over three years. The goal is to see whether the extra imaging helps catch any returning cancer earlier.
Doctors don't yet know whether adding expensive imaging scans to standard follow-up care actually helps patients with advanced melanoma live longer or catch recurrence sooner. This trial will provide that answer.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. Both groups will have regular doctor appointments following standard melanoma monitoring guidelines for three years. The second group will also receive five imaging scans (either CT or PET) during those three years, along with blood tests. You'll need to be able to attend all scheduled visits and complete the follow-up program as assigned.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Sweden